Biomarker Panels Used to Predict Renal Function in Type I Diabetes
In a study published in Diabetologia1, researchers compared blood and urine-based biomarker panels to determine if they can outperform current eGFR se...
KIM-1 & β2-M Predict Rapid Decline in Type 2 Diabetes Renal Function
Serum Kidney Injury Molecule 1 and β2-Microglobulin Perform as well as Larger Biomarker Panels for Prediction of Rapid Decline in Renal Funct...
Effects of Canagliflozin Versus Glimepiride on Adipokines and Inflammatory Biomarkers in Type 2 Diabetes
Timothy Garvey, Luc Van Gaal, Lawrence A. Leiter, Ujjwala Vijapurkar, James List, Robert Cuddihy, Jimmy Ren, Michael J. Davies Metabolism. 2018. doi:...
GDF-15 as a Possible Biomarker for Use and Dosing of Metformin in Type 2 Diabetes
Novel nonglycemic biomarker for metformin The Outcome Reduction with Initial Glargine Intervention (ORIGIN) trial delivers more insight on biomarke...
Identifying Novel Biomarkers for Cardiovascular Events or Death in People With Dysglycemia
An international team of researchers used Myriad RBM’s Multi-Analyte Profile (MAP) technology to identify a pattern of cardiometabolic biomarkers that...
Salivary biomarkers of Type-2 Diabetes Risk in Children
The epidemic of obesity in America is staggering and the costs of treating the diseases associated with being overweight are increasing. The prevalenc...
Myriad Announces Diabetes Collaboration with Sanofi
As a major participant in the largest protein biomarker study of its kind, Myriad RBM will analyze more than 8,000 samples for Sanofi Aventis' Outcome...